Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Caribou Biosciences (CRBU) Current Leases: 2022-2025

Historic Current Leases for Caribou Biosciences (CRBU) over the last 4 years, with Sep 2025 value amounting to $2.7 million.

  • Caribou Biosciences' Current Leases rose 128.10% to $2.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.7 million, marking a year-over-year increase of 128.10%. This contributed to the annual value of $1.4 million for FY2024, which is 18.83% up from last year.
  • According to the latest figures from Q3 2025, Caribou Biosciences' Current Leases is $2.7 million, which was up 17.49% from $2.3 million recorded in Q2 2025.
  • In the past 5 years, Caribou Biosciences' Current Leases registered a high of $2.7 million during Q3 2025, and its lowest value of $825,000 during Q1 2022.
  • Its 3-year average for Current Leases is $1.5 million, with a median of $1.3 million in 2024.
  • Data for Caribou Biosciences' Current Leases shows a peak YoY soared of 128.10% (in 2025) over the last 5 years.
  • Quarterly analysis of 4 years shows Caribou Biosciences' Current Leases stood at $966,000 in 2022, then increased by 24.22% to $1.2 million in 2023, then increased by 18.83% to $1.4 million in 2024, then soared by 128.10% to $2.7 million in 2025.
  • Its Current Leases was $2.7 million in Q3 2025, compared to $2.3 million in Q2 2025 and $1.9 million in Q1 2025.